Form 8-K - Current report:
SEC Accession No. 0001567264-24-000045
Filing Date
2024-10-23
Accepted
2024-10-23 16:20:10
Documents
13
Period of Report
2024-10-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K intensity-20241021.htm   iXBRL 8-K 24323
  Complete submission text file 0001567264-24-000045.txt   155115

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT intensity-20241021.xsd EX-101.SCH 1827
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT intensity-20241021_lab.xml EX-101.LAB 23449
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT intensity-20241021_pre.xml EX-101.PRE 13606
15 EXTRACTED XBRL INSTANCE DOCUMENT intensity-20241021_htm.xml XML 2935
Mailing Address 61 WILTON ROAD, 3RD FLOOR WESTPORT CT 06880
Business Address 61 WILTON ROAD, 3RD FLOOR WESTPORT CT 06880 203-221-7381
INTENSITY THERAPEUTICS, INC. (Filer) CIK: 0001567264 (see all company filings)

EIN.: 461488089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41109 | Film No.: 241389458
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)